Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Toxicity, Drug”

446 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 446 results

Large-scale testing (Phase 3)Ended earlyNCT00662688
What this trial is testing

Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityPancreatic CancerThromboembolism
GERCOR - Multidisciplinary Oncology Cooperative Group 42
Not applicableUnknownNCT05892146
What this trial is testing

Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction

Who this might be right for
Chemotherapeutic ToxicityCardiotoxicityHeart Failure+2 more
National Cheng-Kung University Hospital 100
Testing effectiveness (Phase 2)UnknownNCT01097317
What this trial is testing

First-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityFatigueLung Cancer+1 more
Wales Cancer Trials Unit 52
Testing effectiveness (Phase 2)UnknownNCT01965275
What this trial is testing

High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced NSCLC Patients After Failure of Standard Dose EGFR-TKIs

Who this might be right for
Self EfficacyDrug Toxicity
Anhui Medical University 20
Not applicableActive Not RecruitingNCT07163286
What this trial is testing

Malnutrition and Sarcopenia Screening in Chemotherapy Patients

Who this might be right for
Nutrition Aspect of CancerSarcopeniaChemotherapeutic Agent Toxicity
Çanakkale Onsekiz Mart University 200
Post-approval studies (Phase 4)Study completedNCT03461445
What this trial is testing

Effect of Tacrolimus Formulation on Neurological Side Effects in Older Kidney Transplant Recipients

Who this might be right for
Kidney Transplant; ComplicationsToxicityDrug Toxicity+1 more
University of California, Davis 64
Testing effectiveness (Phase 2)Looking for participantsNCT07269041
What this trial is testing

Immune Tolerance Induction After Liver Transplantation

Who this might be right for
Liver TransplantationImmune ToleranceImmune Tolerance/Drug Effects+6 more
University of California, Los Angeles 12
Not applicableStudy completedNCT03790631
What this trial is testing

The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring

Who this might be right for
Beta-lactam AntibioticsTherapeutic Drug MonitoringToxicity+8 more
University of Geneva, Switzerland 771
Not applicableStudy completedNCT03828942
What this trial is testing

Monitoring the HeMAtological TOXicity of Drugs (HeMATOX)

Who this might be right for
Hematological AbnormalityHematotoxicity
Groupe Hospitalier Pitie-Salpetriere 1,000
Not applicableEnded earlyNCT01243541
What this trial is testing

Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel

Who this might be right for
Chemotherapeutic Agent ToxicityPainPeripheral Neuropathy+9 more
Northwestern University 33
Not applicableLooking for participantsNCT06270667
What this trial is testing

Effects of Exercise Training in Survivors of Lymphoma

Who this might be right for
LymphomaPhysical ExerciseCardiotoxicity+2 more
Norwegian School of Sport Sciences 280
Not applicableStudy completedNCT06817044
What this trial is testing

Optimising Screening for the Cardiotoxic Effects of Cancer Therapy

Who this might be right for
Ventricular DysfunctionCardiotoxicityChemotherapeutic Toxicity
Barts & The London NHS Trust 80
Not applicableUnknownNCT03481192
What this trial is testing

Voluntary Drug Poisoning by Psychoactive Molecules: Identify Cognitive Markers

Who this might be right for
SuicideDrug Poisoning
University Hospital, Toulouse 103
Not applicableLooking for participantsNCT07456592
What this trial is testing

Development of an Aptamer-based Lateral Flow Device for Point-of-care Detection of Toxic Chinese Medicine Herbs (ALPTH Project)

Who this might be right for
Aconite Poisoning
The University of Hong Kong 90
Post-approval studies (Phase 4)Looking for participantsNCT06484530
What this trial is testing

Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis

Who this might be right for
Tuberculosis (TB)Isoniazid ToxicityRifampicin Toxicity+6 more
Mahidol University 116
Testing effectiveness (Phase 2)Active Not RecruitingNCT04305145
What this trial is testing

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVSkin Cancer Stage III+4 more
Massachusetts General Hospital 42
Post-approval studies (Phase 4)Ended earlyNCT03191201
What this trial is testing

A Double Blind Randomised Placebo-controlled Trial to Assess the Role of Iron Repletion in Glucose Homeostasis.

Who this might be right for
Iron-deficiencyIron ToxicityGlucose Metabolism Disorders (Including Diabetes Mellitus)+3 more
Prof Gérard WAEBER 32
Large-scale testing (Phase 3)Study completedNCT00296036
What this trial is testing

Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
Alliance for Clinical Trials in Oncology 137
Post-approval studies (Phase 4)UnknownNCT05106179
What this trial is testing

The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma

Who this might be right for
Spinal TumorSpinal HemangiomaBeta Blocker Toxicity
Center for Vascular Pathology, Moscow 1,000
Testing effectiveness (Phase 2)WithdrawnNCT00372723
What this trial is testing

Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)

Who this might be right for
Toxic Epidermal Necrolysis
Loyola University
Load More Results